Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Comment by Tradertimestwoon Sep 20, 2019 11:09am

125 Views

Post# 30147828

RE:RE:news!

Unreal, embarassing and pitiful that daytraders can trade this back down so easily. Amazing drug with insane potential. I will hold and add for a long time. This drug deserves your patience. Stop flipping pennies.

Pandora wrote: Well it's the day after good news and volume is up but price is down - at this point.
Not what we expect for the follow up on good test results. Hopefully it will get back to at least the 8 cents before the day is out.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?